China Pharma Holdings, Inc.

CPHI NYSE SEC CIK 1106644
Follow China Pharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.2M +52.5% vs same quarter last year
Net income −$1.9M −191.9% vs same quarter last year
EPS, diluted −$0.04 +76.5% vs same quarter last year
Operating cash flow −$1.1M −441.9% vs same quarter last year
Revenue by quarter
$1.1M
$1.1M
$1M
$756.2K
$1.2M
$983.5K
$948.3K
$1.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$50M$0$50M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.1M−$3.2M
FY24$4.5M−$4.7M
FY23$7M−$3.1M
FY22$8.1M−$4M
FY21$9.6M−$3.4M
FY20$10.9M−$2.9M
FY19$10.9M−$20.7M
FY18$12.3M−$10.8M
FY17$13.2M−$19.3M
FY16$15.6M−$9.2M
FY15$20.4M−$15.4M
FY14$22.1M−$39.6M
FY13$32.8M−$20M
FY12$54.5M$4.6M
FY11$81.2M$19.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25−3.2%−78.2%−76.9%
FY24−43.8%−101.3%−104.6%
FY23−4%−39.2%−43.9%
FY22−6.1%−43.8%−49%
FY213.6%−29.7%−35.3%
FY2018%−23.7%−26.4%
FY1913.6%−186.8%−189.5%
FY1816%−84.7%−87.2%
FY1718.7%−141.4%−145.9%
FY1620.7%−52.4%−59%
FY157.2%−70.3%−75.7%
FY1412.1%−175.1%−178.7%
FY13−1.5%−56.7%−61%
FY1225.8%10.8%8.5%
FY1135.7%27.1%23.7%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$88.9K
FY24−$444.5K
FY23−$711.2K
FY22−$811.5K
FY21−$687.9K
FY20−$909.6K
FY19$472.3K
FY18$1.8M
FY17$704.7K
FY16$2.7M
FY15$2.7M
FY14$1M
FY13−$10.2M
FY12$3.5M
FY11$4.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • China Pharma
  • Healthcare median
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearChina PharmaHealthcare median
FY25−76.9%−30.6%
FY24−104.6%−47%
FY23−43.9%−58%
FY22−49%−80.4%
FY21−35.3%−71.9%
FY20−26.4%−62.2%
FY19−189.5%−46.3%
FY18−87.2%−49.6%
FY17−145.9%−45.9%
FY16−59%−36%
FY15−75.7%−38.4%
FY14−178.7%−35.5%
FY13−61%−37.1%
FY128.5%−29.1%
FY1123.7%−27.9%